Most digital pathology initiatives don’t slow down because the technology fails. They slow down when strategy collides with operations.
Early conversations are aspirational: better turnaround time, enterprise collaboration, modernization. Then the evaluation shifts from possibility to proof. Integration details surface. ROI assumptions get pressure-tested. Stakeholders bring competing definitions of “success.” Momentum fades – not because digital isn’t viable, but because operational clarity wasn’t defined early.
The inflection point isn’t technical. It’s organizational. The labs that move forward are the ones that define integration requirements, measurable outcomes, and 12-month success criteria before vendor comparisons begin. Evaluation should reduce uncertainty — not expand it.
If digital pathology evaluations in your organization have slowed, it’s worth asking whether the barrier is truly technical, or whether operational definitions of integration, ROI, and success were never fully aligned. Adoption doesn’t stall because the technology lacks capability. It stalls when clarity comes too late. In our deeper analysis, Digital Pathology Adoption Challenges: A Practical Guide for Pathologists and Lab Directors, we examine the structural factors that determine whether evaluations gain momentum or quietly lose it.
